For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.
Patients who experience severe breathing conditions such as chronic bronchitis and emphysema will benefit from PharmaCare coverage for the medication tiotropium, also known as Spiriva, announced Health Minister George Abbott.
New research challenges the notion frequently communicated in major publications, broadcast media and popular entertainment that women talk significantly more than men.
With the surge of global tourism comes the possibility of exposure to rabies. A new review of the current rabies considerations for travelers is published in the latest issue of Wilderness Medicine.
TMC125 (etravirine, ETR), Tibotec’s investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), demonstrated significant efficacy in patients with NNRTI resistance, according to the 24-week primary endpoint analysis from two ongoing, phase III studies published in the 7 July, 2007, issue of The Lancet.
Patients with type 2 diabetes may soon be able to control their glucose and their cholesterol levels with a single drug, according to a study led by Vivian A. Fonseca, professor of medicine and pharmacology at Tulane University School of Medicine and chief of the Tulane University Health Sciences Center Diabetes Program.
A pioneering collaborative study has discovered how the HIV virus evades the human body?s immune system.
Nearly a quarter of hospital or “healthline” operators mistakenly routed a caller describing classic stroke symptoms to primary care doctors rather than to 9-1-1, according to a research project published in Stroke: Journal of the American Heart Association.
University of Florida and University of Michigan scientists isolated nearly 200 proteins from the urine of patients with and without bladder cancer. Several appear promising as potential biomarkers, including one that studies conducted elsewhere have already linked to liver and ovarian cancer.
People with diabetes are risking their health by not discussing their use of complementary and alternative therapies with the health professionals managing their conventional treatment.